Hôpital Saint Louis Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03454984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hôpital Saint Louis

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Myelodysplastic Syndromes (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 5